An Insertion/Deletion Polymorphism in the Alpha2B Adrenoceptor Gene is Associated with Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus

Abstract

Alpha2B adrenoceptor (alpha2B-AR) mediates a variety of functions in humans. An insertion/deletion (I/D) polymorphism of the alpha2B-AR gene located on chromosome 2 has been described. The aim of the present study was to investigate the potential association between alpha2B gene I/D polymorphism and peripheral neuropathy in Greek patients with type 2 diabetes mellitus. The study included 130 patients (70 men) with diabetic neuropathy (group A) and 60 patients (34 men) without diabetic neuropathy (group B). There was no difference in age, gender and diabetes duration between the groups. Diabetic neuropathy was diagnosed by clinical examination using the Diabetic Neuropathy Index (DNI). Genotyping of I/D polymorphism was performed by PCR. Frequency of the D allele was significantly higher (p=0.001) in group A (26.9%) as compared to group B (11.7%). DNI score differed significantly (p=0.001) between the three genotype groups (I/I, I/D, D/D). It was significantly higher (p=0.04) in patients with I/D (3.7±1) than in those with I/I (2.5±0.9) and significantly higher (p=0.001) in patients with D/D (5.6±1.3) than in those with I/D (3.7±1)

Conclusions: Patients with neuropathy exhibit a significantly higher frequency of the D allele in comparison to those without neuropathy. Presence of the D allele is also associated with a higher neuropathic score. These results provide evidence for an association of the D allele with both presence and severity of neuropathy in patients with type 2 diabetes mellitus.

adrenoceptor - diabetes mellitus - diabetic neuropathy - polymorphism

References

• 1 Bax G, Fagherazzi C, Piarulli F, Nicolucci A, Fedele D. Reproducibility of Michigan Neuropathy Screening Instrument (MNSI).  Diabetes Care. 1996;  19 904-905
• 2 Bedlack RS, Edelman D, Gibbs III JW, Kelling D, Strittmatter W, Saunders AM. et al . APOE genotype is risk factor for neuropathy severity in diabetic patients.  Neurology. 2003;  60 1022-1024
• 3 Boulton AJM, Kirsner RS, Vileikyte L. Neuropathic diabetic foot ulcers.  N Engl J Med. 2004;  351 48-55
• 4 Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D. American Diabetes Association . Diabetic neuropathies: a statement by the American Diabetes Association.  Diabetes Care. 2005;  28 956-962
• 5 Duby JJ, Campbell RK, Setter SM, White JR, Rasmussen KA. Diabetic neuropathy: an intensive review.  Am J Health Syst Pharm. 2004;  61 160-173
• 6 Edmonds ME. The diabetic foot, 2003.  Diabetes Metal Res Rev. 2004;  20 ((Suppl 1)) S9-S12
• 7 Fedele D, Comi G, Coscelli C, Cucinotta D, Feldman EL, Ghirlanda G. et al . A multicenter study on the prevalence of diabetic neuropathy in Italy.  Diabetes Care. 1997;  20 836-843
• 8 Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal L, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy.  Diabetes Care. 1994;  17 1281-1289
• 9 Heinonen P, Koulu M, Pesonen U, Karvonen MK, Rissanen A, Laakso M. et al . Identification of a three-amino acid deletion in the alpha2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects.  J Clin Endocrinol Metab. 1999;  84 2429-2433
• 10 Lomasney JW, Lorenz W, Allen LF, King K, Regan JW, Yang-Feng TL. et al . Expansion of the alpha 2-adrenergic receptor family: cloning and characterization of a human alpha 2-adrenergic receptor subtype, the gene for which is located on chromosome 2.  Proc Natl Acad Sci USA. 1990;  87 5094-5098
• 11 Papanas N, Papatheodorou K, Christakidis, Papazoglou D, Giassakis G, Piperidou H. et al . Evaluation of a new indicator test for sudomotor function (Neuropad^®) in the diagnosis of peripheral neuropathy in type 2 diabetic patients.  Exp Clin Endocrinol Diabetes. 2005;  113 195-198
• 12 Papazoglou D, Papanas N, Papatheodorou K, Kotsiou S, Christakidis D, Maltezos E. An insertion/deletion polymorphism in the alpha2B adrenoceptor gene is associated with age at onset of type 2 diabetes mellitus.  Exp Clin Endocronol Diabetes. 2006;  114 424-427
• 13 Quattrini C, Jeziorska M, Malik RA. Small fiber neuropathy in diabetes: clinical consequence and assessment.  Int J Low Extrem Wounds. 2004;  3 16-21
• 14 Raccah D, Coste TC, Vague P. Genetics of diabetic complications: peripheral neuropathy.  Ann Endocrinol (Paris). 2004;  65 ((Suppl 1)) S5-S9
• 15 Rudofsky Jr G, Schroedter A, Schlotterer A, Voron’ko OE, Schlimme M, Tafel J. et al . Functional polymorphisms of UCP2 and UCP3 are associated with a reduced prevalence of diabetic neuropathy in patients with type 1 diabetes.  Diabetes Care. 2006;  29 89-94
• 16 Shaw JE, Gries FA, Ziegler D. Epidemiology of diabetic neuropathy. In: Gries FA, Low PA, Ziegler D (Eds) Textbook of diabetic neuropathy. New York: Thieme Verlag 2003: 64-79
• 17 Siitonen N, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P. et al . Association between a deletion/insertion polymorphism in the alpha2B-adrenergic receptor gene and insulin secretion and Type 2 diabetes. The Finnish Diabetes Prevention Study.  Diabetologia. 2004;  47 1416-1424
• 18 Sima AA. New insights into the metabolic and molecular basis for diabetic neuropathy.  Cell Mol Life Sci. 2003;  60 2445-2464
• 19 Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy.  Diabetes Care. 2001;  24 1448-1453
• 20 Sivenius K, Lindi V, Niskanen L, Laakso M, Uusitupa M. Effect of a three-amino acid deletion in the alpha2B-adrenergic receptor gene on long-term body weight change in Finnish non-diabetic and type 2 diabetic subjects.  Int J Obes Relat Metab Disord. 2001;  25 1609-1614
• 21 Sivenius K, Niskanen L, Laakso M, Uusitupa M. A deletion in the alpha2B-adrenergic receptor gene and autonomic nervous function in central obesity.  Obes Res. 2003;  11 962-970
• 22 Sivenius K, Pihlajamaki J, Partanen J, Niskanen L, Laakso M, Uusitupa M. Aldose reductase gene polymorphisms and peripheral nerve function in patients with type 2 diabetes.  Diabetes Care. 2004;  27 2021-2026
• 23 Snapir A, Heinonen P, Tuomalainen TP, Alhopuro P, Karvonen MK, Lakka TA. et al . An insertion/deletion polymorphism in the alpha2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events.  J Am Coll Cardiol. 2001;  37 1516-1522
• 24 Sugimoto K, Murakawa Y, Sima AA. Diabetic neuropathy-a continuing enigma.  Diabetes Metab Res Rev. 2000;  16 408-433
• 25 Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance.  Neurology. 2003;  60 108-111
• 26 Suzuki N, Matsunaga T, Nagasumi K, Yamamura T, Shihara N, Moritani T. et al . Alpha(2B)-adrenergic receptor deletion polymorphism associates with autonomic nervous system activity in young healthy Japanese.  J Clin Endocrinol Metab. 2003;  88 1184-1187
• 27 Ueno LM, Frazzatto ES, Batalha LT, Trombetta IC, do Socorro Brasileiro M, Irigoyen C. et al . Alpha2B-adrenergic receptor deletionpolymorphism andcardiac autonomic nervous system responses to exercise in obese women.  Int J Obes (Lond). 2006;  30 214-220
• 28 Veves A, Manes C, Murray HJ, Young MJ, Boulton AJ. Painful neuropathy and foot ulceration in diabetic patients.  Diabetes Care. 1993;  16 1187-1189
• 29 Zhou Z, Hoke A, Cornblath DR, Griffin JW, Polydefkis M. APOE ε4 is not a susceptibility gene in idiopathic or diabetic sensory neuropathy.  Neurology. 2005;  64 139-141

Correspondence